Document Type
Patent
Publication Date
June 2012
Patent Number
8202886
Abstract
A small molecular inhibitor of E2F (HLM006474) was identified using a computer-based virtual screen and the known crystal structure of the DNA bound E2F4/DP2 heterodimer. Treatment of multiple cell lines resulted in the loss of intracellular E2F4 DNA-binding activity. Overnight exposure to HLM006474 resulted in down regulation of total E2F4 protein as well as several known E2F targets. The effects of treatment on different cell lines included a reduction in cell proliferation and an increase in apoptosis. Apoptosis was induced in a manner distinct from cisplatin and doxorubicin. E2F4-null MEFs (mouse embryo fibroblasts) were less sensitive than wildtype counterparts to the apoptosis-inducing activity of the compound revealing its biological specificity. A375 cells were extremely sensitive to the apoptosis-inducing activity of the compound in two-dimensional culture and HLM006474 was a potent inhibitor of melanocytes proliferation and subsequent invasion in a three-dimensional tissue culture model system.
Application Number
12/872,263
Recommended Citation
Cress, Douglas W. and Ma, Yihong, "Small molecule E2F inhibitor" (2012). USF Patents. 331.
https://digitalcommons.usf.edu/usf_patents/331
Assignees
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Filing Date
08/31/2010
Primary/U.S. Class
514/314
